Abatacept Shows Signal to Delay Onset of Rheumatoid Arthritis Abatacept Shows Signal to Delay Onset of Rheumatoid Arthritis
Early results of a randomized clinical trial show that a 6-month course of abatacept may delay or prevent progression to rheumatoid arthritis.Medscape Medical News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Rheumatology News Source Type: news